Effective 30-hour preservation of canine lungs with modified ET-Kyoto solution

Ann Thorac Surg. 1996 Apr;61(4):1099-105. doi: 10.1016/0003-4975(96)00030-6.

Abstract

Background: With the aim of developing a preservation solution that can preserve donor lungs reliably for a long time, we prepared a modified ET-Kyoto solution by adding N-acetylcysteine, nitroglycerin, and dibutyryl adenosine 3', 5'-cyclic phosphate to the previously reported ET-Kyoto solution, which contains trehalose, gluconate, and hydroxyethyl starch. In this study, we examined the efficacy of modified ET-Kyoto solution in 30-hour lung preservation.

Methods: Twenty five pairs of adult mongrel dogs were divided into four groups. Donor lungs were flushed with modified ET-Kyoto solution (n = 9), with ET-Kyoto solution (n = 6), with University of Wisconsin solution group (n = 6), or with ET-Kyoto solution plus the solvents of nitroglycerin (ethanol and propylene glycol) (n = 4), then stored at 4 degrees C for 30 hours. All animals were treated with prostaglandin E1. Left lungs were transplanted and reperfused for 6 hours.

Results: With respect to arterial oxygen tension, peak inspiratory pressure, and wet-to-dry lung weight ratio, modified ET-Kyoto solution was significantly superior to ET-Kyoto solution. The modified ET-Kyoto solution was significantly superior to University of Wisconsin solution with respect to survival rate, arterial oxygen tension, and wet-to-dry lung weight ratio. Ultrastructural findings supported these results.

Conclusions: These results suggest that modified ET-Kyoto solution is superior to University of Wisconsin solution for 30-hour lung preservation.

Publication types

  • Comparative Study

MeSH terms

  • Acetylcysteine / pharmacology*
  • Adenosine / pharmacology
  • Allopurinol / pharmacology
  • Animals
  • Bucladesine / pharmacology*
  • Dogs
  • Drug Evaluation, Preclinical
  • Ethanol / pharmacology
  • Gluconates / pharmacology*
  • Glutathione / pharmacology
  • Hydroxyethyl Starch Derivatives / pharmacology*
  • Insulin / pharmacology
  • Lung / drug effects*
  • Lung / physiology
  • Lung / ultrastructure
  • Lung Transplantation / methods
  • Lung Transplantation / physiology
  • Nitroglycerin / pharmacology*
  • Organ Preservation / methods*
  • Organ Preservation Solutions*
  • Phosphates
  • Propylene Glycol
  • Propylene Glycols / pharmacology
  • Raffinose / pharmacology
  • Random Allocation
  • Reperfusion
  • Solutions
  • Time Factors
  • Trehalose / pharmacology*

Substances

  • ET-Kyoto solution
  • Gluconates
  • Hydroxyethyl Starch Derivatives
  • Insulin
  • Organ Preservation Solutions
  • Phosphates
  • Propylene Glycols
  • Solutions
  • University of Wisconsin-lactobionate solution
  • modified ET-Kyoto solution
  • Ethanol
  • Allopurinol
  • Bucladesine
  • Propylene Glycol
  • Trehalose
  • Nitroglycerin
  • Glutathione
  • Adenosine
  • Raffinose
  • Acetylcysteine